Saturday, May 10, 2014

PATENT: DIAGNOSIS AND TREATMENT OF FRIEDREICH'S ATAXIA

›
DIAGNOSIS AND TREATMENT OF FRIEDREICH'S ATAXIA . Bibliographic data: US2014128455 (A1) ― 2014-05-08 Inventor(s): ZAIN-LUQMAN RULA ...
Thursday, May 8, 2014

Shining a light in the black box of orphan drug pricing

›
Shining a light in the black box of orphan drug pricing . Eline Picavet, Thomas Morel, David Cassiman and Steven Simoens; Orphanet Journal ...
Wednesday, May 7, 2014

Mitochondrial dysfunction affecting visual pathways

›
Mitochondrial dysfunction affecting visual pathways . S. Leruez, P. Amati-Bonneau, C. Verny, P. Reynier, V. Procaccio, D. Bonneau, D. Milea,...
Monday, May 5, 2014

Perspectives of drug-based neuroprotection targeting mitochondria

›
Perspectives of drug-based neuroprotection targeting mitochondria , V. Procaccio, C. Bris, J.M. Chao de la Barca, F. Oca, A. Chevrollier, P....

Genetics of mitochondrial respiratory chain deficiencies

›
Genetics of mitochondrial respiratory chain deficiencies , A. Rötig, Revue Neurologique, Available online 3 May 2014, ISSN 0035-3787, http:/...

The brain is hypothermic in patients with mitochondrial diseases

›
The brain is hypothermic in patients with mitochondrial diseases . Mario Rango, Andrea Arighi, Cristiana Bonifati, Roberto Del Bo, Giacomo C...
Friday, May 2, 2014

R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome

›
R-loops Associated with Triplet Repeat Expansions Promote Gene Silencing in Friedreich Ataxia and Fragile X Syndrome . Groh M, Lufino MMP, ...
Thursday, May 1, 2014

Nicotinamide in Friedreich's ataxia: useful or not?

›
Nicotinamide in Friedreich's ataxia: useful or not? . The Lancet, Available online 30 April 2014, ISSN 0140-6736, http://dx.doi.org/10.1...

Re-activating the Friedreich’s ataxia gene in patients: early promise for a radical treatment

›
Re-activating the Friedreich’s ataxia gene in patients: early promise for a radical treatment Ataxia-UK Press release: 1st May 2014

Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study

›
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-labe...